指南与共识膀胱癌与上尿路尿路上皮癌

英国泌尿科医生对NICE与EAU低中危NMIBC指南的采纳、一致性与可用性调查

Adoption, consistency, and usability of NICE vs EAU guidelines in low- and intermediate-risk NMIBC: a cross-sectional survey of UK urologists.
指南 / 共识 · BJU Int · 2026-06-15

该横断面调查评估英国临床医生对低中危非肌层浸润性膀胱癌(NMIBC)指南的采纳及实际应用一致性。174份有效回复显示,遵循NICE指南者在风险分层和随访时长上与指南一致性显著高于遵循EAU指南者。研究表明NICE指南在低中危疾病中具有更高一致性和实用性,提示需统一推荐以促进公平诊疗和合理利用监测资源。

要点

  • 英国低中危NMIBC指南采纳存在显著差异,单位层面多遵循NICE(38%),个人层面多遵循EAU(39%)。
  • 遵循NICE指南者随访时长符合率显著高于EAU者(78.9% vs 49.2%,P<0.001)。
  • NICE组风险分层一致率77.1%,显著高于EAU组34.1%(P<0.001)。

核心结论

  • 英国低中危NMIBC指南依从性和实际应用存在显著差异,NICE指南在一致性和实用性上优于EAU指南。

研究设计与样本

  • 横断面调查,面向英国参与NMIBC管理的临床医生,共分析174份有效回复,使用三个基于真实病例的场景评估决策与自报指南的一致性。

主要发现

  • 38%的单位遵循NICE指南,但个人层面最常报告遵循EAU指南(39%)。
  • 遵循NICE指南者随访时长符合率78.9%,显著高于EAU者的49.2%(P<0.001)。
  • NICE组风险分层一致率77.1%,显著高于EAU组的34.1%(P<0.001)。
  • NICE组偏离指南主要表现为监测时长超过推荐,EAU组则常缩短随访(P<0.001)。
  • 出院时可接受的复发风险在两组间无显著差异(P=0.278)。

关键数值与推荐

  • 遵循NICE指南者随访时长符合率78.9% vs EAU者49.2%(P<0.001)。
  • NICE组风险分层一致率77.1% vs EAU组34.1%(P<0.001)。
  • 出院复发风险接受度组间无差异(P=0.278)。

临床怎么用

  • 在低中危NMIBC管理中,采用NICE指南可能提高风险分层和随访时长决策的一致性。
  • 需关注遵循EAU指南者倾向于缩短随访的现象,避免监测不足。
  • 应推动更清晰统一的推荐,以促进公平诊疗和合理使用监测资源。

局限性

  • 横断面调查设计无法推断因果,结果基于自报指南和病例场景决策,可能受回忆偏倚和社会期望偏倚影响。
  • 样本仅来自英国,结论外推至其他医疗体系需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate current adoption of guidelines for low- and intermediate-risk non-muscle-invasive bladder cancer (NMIBC) in the UK and to assess clinicians' ability to apply their chosen guideline consistently to real-world clinical scenarios. PATIENTS AND METHODS: This study is a cross-sectional survey distributed to clinicians involved in the management of NMIBC in the UK. Respondents reported their unit-level and personal guideline adoption (National Institute for Health and Care Excellence [NICE] vs European Association of Urology [EAU]) and completed three case-based real-life scenarios derived from NMIBC cases with discordant risk stratification between NICE and EAU guidelines. Cases were randomly selected from a local database using a computer-generated random number function in Microsoft Excel. Concordance between respondents' decisions and their stated guideline was assessed for risk stratification and surveillance duration. RESULTS: A total of 174 eligible responses were analysed. Most units (38%) followed NICE guidelines, but individual clinicians most frequently reported that they were following EAU guidelines (39%). Those who followed NICE guidelines demonstrated significantly higher compliance with the duration of follow-up as recommended in the guidelines than did those who followed EAU guidelines (78.9% vs 49.2%, P < 0.001). Deviations from the guidelines for those who followed NICE were predominantly in duration of surveillance, which was longer than recommended. Conversely, those following EAU guidelines frequently opted for shorter-than-recommended follow-up (P < 0.001). Consistent guideline-based risk stratification was achieved in 77.1% of those following NICE guidelines and 34.1% of those following EAU guidelines (P < 0.001). Acceptable recurrence risk at discharge did not differ between guideline groups (P = 0.278). CONCLUSIONS: Substantial variation exists in NMIBC guideline adherence and real-world application in the UK. NICE guidance was associated with greater consistency and utility compared with EAU guidance for low- and intermediate-risk disease. These findings highlight the need for clearer, unified recommendations to promote equitable care and rational use of surveillance resources.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ibrahim Y, Ribeiro L, Spazzapan M, et al. Adoption, consistency, and usability of NICE vs EAU guidelines in low- and intermediate-risk NMIBC: a cross-sectional survey of UK urologists. BJU Int. 2026. PMID: 42299040. doi:10.1111/bju.70354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。